Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale

Journal of Invasive Cardiology

Volumn 18, Issue 11, 2006, Pages 533-537

  Zajarias, Alan ^a   Thanigaraj, Srihari ^a   Lasala, John ^a   Perez, Julio ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ADULT; ANTICOAGULANT THERAPY; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ANEURYSM; HEART ATRIUM SEPTUM; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PARADOXICAL EMBOLISM; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; VALSALVA MANEUVER;

ADULT; AGED; BALLOON OCCLUSION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33750689205     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
2. Holmes DR, Cohen H, Katz WE, Reeder GS. Patent foramen ovale, systemic embolization and closure. Curr Probl Cardiol 2004;29:60-94.
3. Scwerzmann, M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-1401.
4. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
5. Windecker W, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758.
6. Waigth DJ, Cao QL, Hijazi ZM. Closure of patent foramen ovale in patients with orthodeoxia-platypnea using Amplatzer devices. Catheter Cardiovasc Interv 2000;50:195-198.
7. Mugge A, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients: A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785-2792.
8. Hong TE, Thaler D, Brorson J, et al. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the Amplatzer PFO Occluder: Initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv 2003;60:524-528.
9. Alameddine F, Block P. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: Acute results form the FORECAST registry. Catheter Cardiovasc Interv 2004;62:512-516.
10. Hung J, Landzberg M, Jenkins K, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
11. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25:424-430.
12. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or both. N Engl J Med 2001;345:1740-1746.
13. Mas JL, Zuber M, et al. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J 1995;130:1083-1088.
14. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Long term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.